Asset Commercialization Partner, Emerging Biopharma

The Asset Commercialization Partner, Emerging Biopharma (EBP) is a trusted advisor to IQVIAs EBP clients, incorporating deep expertise in commercialization and launch to support the development, enablement and execution of their commercialization strategies.

The Asset Commercialization Partner will utilize the full spectrum of IQVIAs resources to develop complex integrated solutions that enable successful commercialization strategies and first-in-class delivery for EBP clients across therapeutic areas in the United States.

The Asset Commercialization Partner will:

• Develop and deliver insightful, value-added commercialization strategies that address complex EBP client needs
• Build trusted partner status via deep commercial content expertise, act as a thought leader for clients and delivery teams
• Conduct strategy sessions with clients to outline an integrated commercial launch plan, with regular check-ins to assess progress and address questions
• Leverage prioritization frameworks to focus pre-commercial team effort on accounts that are likely to launch on their own and provide IQVIA a positive engagement return-on-investment
• Prepare analytical proof points and recommendations for launch critical success factors aligned with IQVIAs proposed client solutions and launch perspectives
• Lead senior/executive level meetings with clients to support launch planning, market, and therapy area insights, and overall solution design and rationale
• Act as principal owner of client engagements; ultimate responsibility for client satisfaction and delivering high levels of quality/added value
• Create and elevate new business opportunities through the identification of value-added follow-on work and identify new revenue opportunities with existing and new client organizations
• Mentor, coach, and share subject matter expertise with others to help develop individuals and capabilities delivering world-class solutions for clients
• Partner with